speb/financial-data huggingface dataset:
PHI1.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2794000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2794000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -328000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Cash Equivalents: 2086000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 2086000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Cash Financial: 708000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Cash Financial: 708000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 107000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -322000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -736000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -196000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1170000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1391000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Cash Flow From Discontinued Operation: -10000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Discontinued Operation: 0.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Account Payable: 97000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 360000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Inventory: -115000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Inventory: 355000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 54000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 50000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1215000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -9000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Payable: 97000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Payable: 360000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 97000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 360000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Receivables: -53000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -175000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: -1232000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 581000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -9000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Changes In Cash: 532000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 872000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Common Stock: 193000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 193000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -328000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 10957000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 10957000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 13000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 5000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Construction In Progress: 274000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 274000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Cost Of Revenue: 9776000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2810000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1737000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1737000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Assets: 9932000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Assets: 9932000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 207000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 207000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Debt: 793000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Debt: 793000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1000000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1000000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1490000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1490000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1490000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1490000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Liabilities: 7511000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 7511000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Current Provisions: 712000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 712000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Deferred Income Tax: 282000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 74000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Deferred Tax: 282000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Deferred Tax: 74000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Depreciation: 602000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Depreciation: -244000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1124000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 278000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1124000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 278000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 123000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 123000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Diluted Average Shares: 962503000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 965914000.00
PHI1.DE income_statement (annual, 2025-12-31) — Diluted EPS: 0.94
PHI1.DE income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.42
PHI1.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 895000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 395000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 13000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 0.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 19000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 19000000.00
PHI1.DE income_statement (annual, 2025-12-31) — EBIT: 1476000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — EBIT: 522000000.00
PHI1.DE income_statement (annual, 2025-12-31) — EBITDA: 2600000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — EBITDA: 800000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -9000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -3000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 9000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 2000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -139000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 10000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — End Cash Position: 2794000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 2794000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 380000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 380000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: 107000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -322000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Finished Goods: 1287000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1287000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 347000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 347000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 504000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 1199000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Gain On Sale Of Business: -25000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: 1000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -17000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 291000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 291000000.00
PHI1.DE income_statement (annual, 2025-12-31) — General And Administrative Expense: 628000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 158000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Goodwill: 9271000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 9271000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 11840000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 11840000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 3532000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3532000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Gross PPE: 5923000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 5923000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Gross Profit: 8058000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Gross Profit: 2288000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 81000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 81000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Income Tax Payable: 174000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 174000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Interest Expense: 294000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 56000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 294000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 56000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Interest Income: 83000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Interest Income: 8000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 83000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 8000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -253000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -40000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Interest Payable: 95000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Interest Payable: 95000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Interest Received Cfo: 83000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 23000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Inventory: 2870000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Inventory: 2870000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Invested Capital: 17804000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 17804000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -737000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -196000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 704000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 704000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Investments And Advances: 852000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 852000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 148000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 148000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 13000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 5000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1057000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 10000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Land And Improvements: 1105000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1105000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Leases: 1328000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Leases: 1328000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Line Of Credit: 52000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 52000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 757000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 757000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Long Term Debt: 6054000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 6054000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6811000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6811000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1057000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 16000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -609000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 148000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 148000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 915000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 915000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1550000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1550000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Minority Interest: 32000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Minority Interest: 32000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Minority Interests: -1000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Minority Interests: -2000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -25000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -18000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 13000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 5000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Net Debt: 4053000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Net Debt: 4053000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Income: 895000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Income: 395000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 895000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 395000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 901000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 393000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: -4000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 4000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 895000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 395000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 899000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 391000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 901000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 394000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 897000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 398000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -136000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -44000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Interest Income: -216000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: -53000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -52000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 12000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 424000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -327000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 448000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -593000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -216000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -53000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Net PPE: 2218000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 2218000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 9000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 2000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -24000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 266000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -883000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -883000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 210000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 210000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1773000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1773000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 551000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 551000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 458000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 458000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1773000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1773000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 93000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 93000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Normalized EBITDA: 2641000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 800000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Normalized Income: 930324000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 391000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1172000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1391000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Operating Gains Losses: 32000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 27000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Operating Income: 1449000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Operating Income: 565000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Operating Revenue: 17461000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 4725000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 951288934.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 951288934.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Current Assets: -5000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: -5000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 741000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 741000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 321000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 321000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -56000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -56000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Equity Interest: -16000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -16000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Other Gand A: 628000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Other Gand A: 158000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Other Income Expense: -50000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Other Income Expense: -44000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2569000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2569000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 294000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 73000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 119000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 119000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 44000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 44000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: -61000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -9000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Payable: 17000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Payable: 17000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Properties: 1666000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Properties: 1666000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Other Receivables: 527000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 527000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Payables: 2251000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Payables: 2251000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3988000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3988000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Prepaid Assets: 180000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 180000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Pretax Income: 1182000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Pretax Income: 466000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Properties: 0.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PHI1.DE cash_flow (annual, 2025-12-31) — Purchase Of Business: -25000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -16000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -136000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -44000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -113000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -7000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Raw Materials: 1175000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1175000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Receivables: 3945000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Receivables: 3945000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 9776000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2810000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1124000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 278000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -609000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -313000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
PHI1.DE income_statement (annual, 2025-12-31) — Research And Development: 1700000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Research And Development: 427000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: 3575000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3575000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Sale Of Investment: 61000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 19000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Sale Of PPE: 9000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 2000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 4342000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 1147000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Selling General And Administration: 4970000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1305000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Share Issued: 962920132.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 962920132.00
PHI1.DE income_statement (annual, 2025-12-31) — Special Income Charges: -24000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Stock Based Compensation: 141000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 30000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 10957000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 10957000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: -883000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -883000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -9676000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PHI1.DE income_statement (annual, 2025-12-31) — Tax Provision: 282000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Tax Provision: 74000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.24
PHI1.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
PHI1.DE balance_sheet (annual, 2025-12-31) — Taxes Receivable: 60000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 60000000.00
PHI1.DE cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -213000000.00
PHI1.DE cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -49000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Assets: 26944000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 26944000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 17011000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 17011000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Debt: 7811000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 7811000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 10989000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 10989000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Total Expenses: 16385000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 4533000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 15955000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 15955000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 17012000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 17012000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 8444000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 8444000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1424000000.00
PHI1.DE income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 540000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Total Other Finance Cost: 5000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Total Tax Payable: 307000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 307000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Total Unusual Items: -41000000.00
PHI1.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -41000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 11631198.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 11631198.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Treasury Stock: 298000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 298000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Work In Process: 408000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Work In Process: 408000000.00
PHI1.DE balance_sheet (annual, 2025-12-31) — Working Capital: 2421000000.00
PHI1.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: 2421000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 1524000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 3905000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1990000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3262000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 7212000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 70000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 951572000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 0.16
PHI1.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2794000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -163000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -136000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 193000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2592000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2592000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -23000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -406000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 190000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Discontinued Operation: 0.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -115000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Inventory: -226000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 18000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -159000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Payable: -115000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -115000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Receivables: 219000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -263000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: -241000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 193000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 11392000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 12000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2140000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1325000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 9784000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Debt: 1206000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1206000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1617000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1617000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7432000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 602000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 44000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Deferred Tax: 44000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 265000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 265000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 265000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 968530000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.16
PHI1.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 151000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 7000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — EBIT: 273000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — EBITDA: 538000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -4000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 4000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 39000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 2592000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -23000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: 604000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 25000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 527000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 177000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 9611000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12296000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 1766000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 77000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 198000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 83000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 83000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Interest Income: 35000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 35000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -55000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 23000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 3110000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 19489000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -406000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 708000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 850000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 142000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 12000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 21000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 6891000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 6891000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 10000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 142000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 879000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Minority Interest: 26000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Minority Interests: 5000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -221000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 12000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Net Debt: 5505000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Income: 151000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 151000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 146000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 151000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 151000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 146000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 146000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -27000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -48000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -25000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -34000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 10000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -48000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 2181000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 3000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -44000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -904000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 220000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 1814000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 529000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 438000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 1814000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 91000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 538000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 151000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 188000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 17000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Operating Income: 242000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 3905000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 952018000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 628000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 1206000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 494000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 18000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 12000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Other Gand A: 177000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Other Income Expense: -4000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2685000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 8000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 121000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 117000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -54000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Payables: 2188000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3513000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 190000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -229000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -27000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -49000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Receivables: 3307000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2140000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 265000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -55000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Research And Development: 394000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 3713000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Sale Of Business: 8000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 24000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 3000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1007000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1184000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 962920132.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 11000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -55000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 30000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 11392000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -904000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 44000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 45000000.00
PHI1.DE cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -34000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 27266000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 18283000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 8097000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 11418000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 3664000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 15848000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 17482000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 8416000000.00
PHI1.DE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 241000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 198000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 10902132.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 265000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Unrealized Gain Loss: -95000000.00
PHI1.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: 2352000000.00
PHIA.AS balance_sheet (annual, 2021-12-31) — Financial Assets: 2000000.00
PHIA.AS balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 47000000.00
PHIA.AS cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 1000000.00
PHIA.AS balance_sheet (annual, 2021-12-31) — Other Inventories: 1000000.00
PHIA.AS balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 2000000.00
PHIA.AS cash_flow (annual, 2021-12-31) — Sale Of Business: 107000000.00
PHIA.AS balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 544000000.00
PHIA.AS balance_sheet (annual, 2021-12-31) — Unrealized Gain Loss: -344000000.00
PHIA.AS income_statement (annual, 2022-12-31) — +Operating Expense: 7371000000.00
PHIA.AS income_statement (annual, 2022-12-31) — +Total Revenue: 17827000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Accounts Payable: 1968000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3832000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3609000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 5025000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -226000000.00
PHIA.AS cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 891000000.00
PHIA.AS cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 891000000.00
PHIA.AS cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 1357000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 77000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 338000000.00
PHIA.AS income_statement (annual, 2022-12-31) — Basic Average Shares: 952457436.00
PHIA.AS income_statement (annual, 2022-12-31) — Basic EPS: -1.68
PHIA.AS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2303000000.00
PHIA.AS cash_flow (annual, 2022-12-31) — Capital Expenditure: -806000000.00
PHIA.AS cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -701000000.00
PHIA.AS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1082000000.00